A Clinical Trial to Evaluate Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignancy

NCT05068921 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cervical Cancer

Interventions

DRUG: TQB2858 injection

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.